Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 3/20 | 0.63 |
| ▸ | PER2 | O15055 | 2/20 | 0.40 |
| ▸ | CRY2 | Q49AN0 | 2/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8283594 | 0.90 | PIK3CD (0.49) | PIK3CDPER2CRY2GRM2 | |
| SCHEMBL13804489 | 0.78 | PIK3CD (0.59) | PIK3CDPER2CRY2GRM2GRIN1 | |
| SCHEMBL8282897 | 0.78 | PIK3CD (1.00) | PIK3CDPER2CRY2GRM2GRIN1 | |
| SCHEMBL13791864 | 0.77 | PIK3CD (0.62) | PIK3CDPER2CRY2GRM2GRIN1 | |
| SCHEMBL12228958 | 0.75 | PIK3CD (0.59) | PIK3CDPER2CRY2GRM2GRIN1 | |
| SCHEMBL8239457 | 0.75 | SMN1; SMN2 (0.43) | PIK3CDPER2CRY2GRIN1GRIN2B | |
| SCHEMBL13622786 | 0.75 | PIK3CD (0.55) | PIK3CDPER2CRY2GRM2GRIN1 | |
| SCHEMBL8282119 | 0.75 | PIK3CD (0.55) | PIK3CDPER2CRY2GRM2GRIN1 | |
| SCHEMBL8250636 | 0.75 | PIK3CD (0.59) | PIK3CDPER2 | |
| SCHEMBL4126996 | 0.75 | PIK3CD (0.59) | PIK3CDPER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730142-B1 | NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS | SCHERING CORP (US) | 2011-06-29 | — | — | EP | disclosed |
| WO-2006130686-A2 | HCV PROTEASE INHIBITORS IN COMBINATION WITH FOOD | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006130553-A2 | HCV PROTEASE INHIBITORS | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006130687-A2 | LIVER/PLASMA CONCENTRATION RATIO FOR DOSING HEPATITIS C VIRUS PROTEASE INHIBITOR | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006130607-A2 | CONTROLLED-RELEASE FORMULATION USEFUL FOR TREATING DISORDERS ASSOCIATED WITH HEPATITIS C VIRUS | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006130552-A2 | METHODS OF TREATING HEPATITIS C VIRUS | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006130688-A2 | COMPOUNDS FOR INHIBITING CATHEPSIN ACTIVITY | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006130554-A2 | METHODS OF TREATING HEPATITIS C VIRUS | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006130627-A2 | METHODS FOR TREATING HEPATITIS C | SCHERING CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| WO-2005085242-A1 | NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS | SCHERING CORPORATION (US) | 2005-09-15 | — | — | WO | disclosed |